Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Correction: Polarized Cell Division of Chlamydia trachomatis.

Abdelrahman Y, Ouellette SP, Belland RJ, Cox JV.

PLoS Pathog. 2016 Aug 30;12(8):e1005866. doi: 10.1371/journal.ppat.1005866. eCollection 2016 Aug.

2.

Comparative Transcriptional Analyses of Francisella tularensis and Francisella novicida.

Sarva ST, Waldo RH, Belland RJ, Klose KE.

PLoS One. 2016 Aug 18;11(8):e0158631. doi: 10.1371/journal.pone.0158631. eCollection 2016.

3.

Polarized Cell Division of Chlamydia trachomatis.

Abdelrahman Y, Ouellette SP, Belland RJ, Cox JV.

PLoS Pathog. 2016 Aug 9;12(8):e1005822. doi: 10.1371/journal.ppat.1005822. eCollection 2016 Aug. Erratum in: PLoS Pathog. 2016 Aug;12(8):e1005866.

4.

Identification and Partial Characterization of Potential FtsL and FtsQ Homologs of Chlamydia.

Ouellette SP, Rueden KJ, AbdelRahman YM, Cox JV, Belland RJ.

Front Microbiol. 2015 Nov 13;6:1264. doi: 10.3389/fmicb.2015.01264. eCollection 2015.

5.

Chlamydia trachomatis utilizes the mammalian CLA1 lipid transporter to acquire host phosphatidylcholine essential for growth.

Cox JV, Abdelrahman YM, Peters J, Naher N, Belland RJ.

Cell Microbiol. 2016 Mar;18(3):305-18. doi: 10.1111/cmi.12523. Epub 2015 Oct 16.

PMID:
26381674
6.

Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections.

Bruhn DF, Waidyarachchi SL, Madhura DB, Shcherbakov D, Zheng Z, Liu J, Abdelrahman YM, Singh AP, Duscha S, Rathi C, Lee RB, Belland RJ, Meibohm B, Rosch JW, Böttger EC, Lee RE.

Sci Transl Med. 2015 May 20;7(288):288ra75. doi: 10.1126/scitranslmed.3010572.

7.

Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested.

Grayston JT, Belland RJ, Byrne GI, Kuo CC, Schachter J, Stamm WE, Zhong G.

Pathog Dis. 2015 Feb;73(1):1-9. doi: 10.1093/femspd/ftu015. Epub 2014 Dec 4. Review. No abstract available.

8.

Morphologic and molecular evaluation of Chlamydia trachomatis growth in human endocervix reveals distinct growth patterns.

Lewis ME, Belland RJ, AbdelRahman YM, Beatty WL, Aiyar AA, Zea AH, Greene SJ, Marrero L, Buckner LR, Tate DJ, McGowin CL, Kozlowski PA, O'Brien M, Lillis RA, Martin DH, Quayle AJ.

Front Cell Infect Microbiol. 2014 Jun 10;4:71. doi: 10.3389/fcimb.2014.00071. eCollection 2014.

9.

Type II fatty acid synthesis is essential for the replication of Chlamydia trachomatis.

Yao J, Abdelrahman YM, Robertson RM, Cox JV, Belland RJ, White SW, Rock CO.

J Biol Chem. 2014 Aug 8;289(32):22365-76. doi: 10.1074/jbc.M114.584185. Epub 2014 Jun 23.

10.

Influence of the tryptophan-indole-IFNγ axis on human genital Chlamydia trachomatis infection: role of vaginal co-infections.

Aiyar A, Quayle AJ, Buckner LR, Sherchand SP, Chang TL, Zea AH, Martin DH, Belland RJ.

Front Cell Infect Microbiol. 2014 Jun 3;4:72. doi: 10.3389/fcimb.2014.00072. eCollection 2014. Review.

11.

Host HDL biogenesis machinery is recruited to the inclusion of Chlamydia trachomatis-infected cells and regulates chlamydial growth.

Cox JV, Naher N, Abdelrahman YM, Belland RJ.

Cell Microbiol. 2012 Oct;14(10):1497-512. doi: 10.1111/j.1462-5822.2012.01823.x. Epub 2012 Jun 26.

12.

Plasmid-cured Chlamydia caviae activates TLR2-dependent signaling and retains virulence in the guinea pig model of genital tract infection.

Frazer LC, Darville T, Chandra-Kuntal K, Andrews CW Jr, Zurenski M, Mintus M, AbdelRahman YM, Belland RJ, Ingalls RR, O'Connell CM.

PLoS One. 2012;7(1):e30747. doi: 10.1371/journal.pone.0030747. Epub 2012 Jan 24.

13.

Inhibition of indoleamine 2,3-dioxygenase activity by levo-1-methyl tryptophan blocks gamma interferon-induced Chlamydia trachomatis persistence in human epithelial cells.

Ibana JA, Belland RJ, Zea AH, Schust DJ, Nagamatsu T, AbdelRahman YM, Tate DJ, Beatty WL, Aiyar AA, Quayle AJ.

Infect Immun. 2011 Nov;79(11):4425-37. doi: 10.1128/IAI.05659-11. Epub 2011 Sep 12.

14.

Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum.

O'Connell CM, AbdelRahman YM, Green E, Darville HK, Saira K, Smith B, Darville T, Scurlock AM, Meyer CR, Belland RJ.

Infect Immun. 2011 Mar;79(3):1044-56. doi: 10.1128/IAI.01118-10. Epub 2011 Jan 3.

15.

Developmental expression of non-coding RNAs in Chlamydia trachomatis during normal and persistent growth.

Abdelrahman YM, Rose LA, Belland RJ.

Nucleic Acids Res. 2011 Mar;39(5):1843-54. doi: 10.1093/nar/gkq1065. Epub 2010 Nov 4.

16.

Antifungal activity of medicinal plant extracts; preliminary screening studies.

Webster D, Taschereau P, Belland RJ, Sand C, Rennie RP.

J Ethnopharmacol. 2008 Jan 4;115(1):140-6. Epub 2007 Sep 25.

PMID:
17996411
17.

Proteome cataloging and relative quantification of Francisella tularensis tularensis strain Schu4 in 2D PAGE using preparative isoelectric focusing.

Waldo RH, Cummings ED, Sarva ST, Brown JM, Lauriano CM, Rose LA, Belland RJ, Klose KE, Hilliard GM.

J Proteome Res. 2007 Sep;6(9):3484-90. Epub 2007 Jul 21.

PMID:
17658781
18.

The p47 GTPases Iigp2 and Irgb10 regulate innate immunity and inflammation to murine Chlamydia psittaci infection.

Miyairi I, Tatireddigari VR, Mahdi OS, Rose LA, Belland RJ, Lu L, Williams RW, Byrne GI.

J Immunol. 2007 Aug 1;179(3):1814-24.

19.

Global transcriptional upregulation in the absence of increased translation in Chlamydia during IFNgamma-mediated host cell tryptophan starvation.

Ouellette SP, Hatch TP, AbdelRahman YM, Rose LA, Belland RJ, Byrne GI.

Mol Microbiol. 2006 Dec;62(5):1387-401. Epub 2006 Oct 24.

20.

Different growth rates of Chlamydia trachomatis biovars reflect pathotype.

Miyairi I, Mahdi OS, Ouellette SP, Belland RJ, Byrne GI.

J Infect Dis. 2006 Aug 1;194(3):350-7. Epub 2006 Jun 22.

PMID:
16826483
21.

The Chlamydia pneumoniae type III secretion-related lcrH gene clusters are developmentally expressed operons.

Ouellette SP, Abdelrahman YM, Belland RJ, Byrne GI.

J Bacteriol. 2005 Nov;187(22):7853-6.

22.

The chlamydial developmental cycle.

Abdelrahman YM, Belland RJ.

FEMS Microbiol Rev. 2005 Nov;29(5):949-59. Review.

23.

Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates.

Carlson JH, Hughes S, Hogan D, Cieplak G, Sturdevant DE, McClarty G, Caldwell HD, Belland RJ.

Infect Immun. 2004 Dec;72(12):7063-72.

24.

Chlamydia pneumoniae and atherosclerosis.

Belland RJ, Ouellette SP, Gieffers J, Byrne GI.

Cell Microbiol. 2004 Feb;6(2):117-27. Review.

PMID:
14706098
25.

Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation.

Belland RJ, Nelson DE, Virok D, Crane DD, Hogan D, Sturdevant D, Beatty WL, Caldwell HD.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15971-6. Epub 2003 Dec 12.

26.

Genotypic differences in the Chlamydia pneumoniae tyrP locus related to vascular tropism and pathogenicity.

Gieffers J, Durling L, Ouellette SP, Rupp J, Maass M, Byrne GI, Caldwell HD, Belland RJ.

J Infect Dis. 2003 Oct 15;188(8):1085-93. Epub 2003 Oct 10.

PMID:
14551876
27.

Micromanipulation of the Chlamydia pneumoniae inclusion: implications for cloning and host-pathogen interactions.

Gieffers J, Tamplin V, Maass M, Belland RJ, Caldwell HD.

FEMS Microbiol Lett. 2003 Sep 12;226(1):45-9.

28.

Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis.

Belland RJ, Zhong G, Crane DD, Hogan D, Sturdevant D, Sharma J, Beatty WL, Caldwell HD.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8478-83. Epub 2003 Jun 18.

29.

Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates.

Caldwell HD, Wood H, Crane D, Bailey R, Jones RB, Mabey D, Maclean I, Mohammed Z, Peeling R, Roshick C, Schachter J, Solomon AW, Stamm WE, Suchland RJ, Taylor L, West SK, Quinn TC, Belland RJ, McClarty G.

J Clin Invest. 2003 Jun;111(11):1757-69.

30.

Isolation of Chlamydia pneumoniae clonal variants by a focus-forming assay.

Gieffers J, Belland RJ, Whitmire W, Ouellette S, Crane D, Maass M, Byrne GI, Caldwell HD.

Infect Immun. 2002 Oct;70(10):5827-34.

31.

Molecular basis defining human Chlamydia trachomatis tissue tropism. A possible role for tryptophan synthase.

Fehlner-Gardiner C, Roshick C, Carlson JH, Hughes S, Belland RJ, Caldwell HD, McClarty G.

J Biol Chem. 2002 Jul 26;277(30):26893-903. Epub 2002 May 13.

32.
33.

Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes.

Belland RJ, Scidmore MA, Crane DD, Hogan DM, Whitmire W, McClarty G, Caldwell HD.

Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13984-9. Epub 2001 Nov 13.

34.
35.
36.

The ihf mRNA levels decline as Neisseria gonorrhoeae enters the stationary growth phase.

Hill SA, Belland RJ, Wilson J.

Gene. 1998 Jul 30;215(2):303-10.

PMID:
9714829
37.

CD66 receptor specificity exhibited by neisserial Opa variants is controlled by protein determinants in CD66 N-domains.

Bos MP, Kuroki M, Krop-Watorek A, Hogan D, Belland RJ.

Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9584-9.

38.
39.

Integration host factor is a transcriptional cofactor of pilE in Neisseria gonorrhoeae.

Hill SA, Samuels DS, Carlson JH, Wilson J, Hogan D, Lubke L, Belland RJ.

Mol Microbiol. 1997 Feb;23(4):649-56.

40.

Selection of Opa+ Neisseria gonorrhoeae by limited availability of normal human serum.

Bos MP, Hogan D, Belland RJ.

Infect Immun. 1997 Feb;65(2):645-50.

41.

Promoter strength influences phase variation of neisserial opa genes.

Belland RJ, Morrison SG, Carlson JH, Hogan DM.

Mol Microbiol. 1997 Jan;23(1):123-35.

42.

Identification of an EF-Tu protein that is periplasm-associated and processed in Neisseria gonorrhoeae.

Porcella SF, Belland RJ, Judd RC.

Microbiology. 1996 Sep;142 ( Pt 9):2481-9.

PMID:
8828215
43.

Adherence of pilus- Opa+ gonococci to epithelial cells in vitro involves heparan sulfate.

Chen T, Belland RJ, Wilson J, Swanson J.

J Exp Med. 1995 Aug 1;182(2):511-7.

44.

Heparin protects Opa+ Neisseria gonorrhoeae from the bactericidal action of normal human serum.

Chen T, Swanson J, Wilson J, Belland RJ.

Infect Immun. 1995 May;63(5):1790-5.

45.

Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.

Belland RJ, Morrison SG, Ison C, Huang WM.

Mol Microbiol. 1994 Oct;14(2):371-80.

PMID:
7830580
46.

Neisserial surface variation: how and why?

Swanson J, Belland RJ, Hill SA.

Curr Opin Genet Dev. 1992 Oct;2(5):805-11. Review.

PMID:
1360853
47.

Human neutrophil response to recombinant neisserial Opa proteins.

Belland RJ, Chen T, Swanson J, Fischer SH.

Mol Microbiol. 1992 Jul;6(13):1729-37.

PMID:
1630313
48.

H-DNA formation by the coding repeat elements of neisserial opa genes.

Belland RJ.

Mol Microbiol. 1991 Oct;5(10):2351-60.

PMID:
1791751
49.

Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein.

Morrison RP, Belland RJ, Lyng K, Caldwell HD.

J Exp Med. 1989 Oct 1;170(4):1271-83.

50.

Supplemental Content

Loading ...
Support Center